DK1140149T3 - Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation...... - Google Patents

Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......

Info

Publication number
DK1140149T3
DK1140149T3 DK99965579T DK99965579T DK1140149T3 DK 1140149 T3 DK1140149 T3 DK 1140149T3 DK 99965579 T DK99965579 T DK 99965579T DK 99965579 T DK99965579 T DK 99965579T DK 1140149 T3 DK1140149 T3 DK 1140149T3
Authority
DK
Denmark
Prior art keywords
growth hormone
antibalstic
transplant
therapies
restore
Prior art date
Application number
DK99965579T
Other languages
Danish (da)
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1140149T3 publication Critical patent/DK1140149T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99965579T 1998-12-30 1999-12-30 Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation...... DK1140149T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
DK1140149T3 true DK1140149T3 (da) 2007-02-19

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99965579T DK1140149T3 (da) 1998-12-30 1999-12-30 Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......

Country Status (15)

Country Link
US (1) US20060029581A1 (pt)
EP (3) EP1016413A1 (pt)
JP (1) JP4808316B2 (pt)
AT (1) ATE342064T1 (pt)
AU (2) AU772222B2 (pt)
BR (1) BR9916726A (pt)
CA (1) CA2354194A1 (pt)
CY (1) CY1107603T1 (pt)
DE (1) DE69933581T2 (pt)
DK (1) DK1140149T3 (pt)
ES (1) ES2275359T3 (pt)
IL (2) IL143994A0 (pt)
PT (1) PT1140149E (pt)
SI (1) SI1140149T1 (pt)
WO (1) WO2000040260A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040028649A1 (en) * 2000-06-07 2004-02-12 GIANNI Alessandro Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
LT2371361T (lt) * 2001-07-31 2019-09-10 Genzyme Corporation Pirmtakų/kamieninių ląstelių suaktyvinimo būdai
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
CN104017063A (zh) * 2009-12-21 2014-09-03 Ambrx公司 经过修饰的猪促生长素多肽和其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
ES2172536T3 (es) * 1993-06-15 2002-10-01 British Biotech Pharm Liberacion y movilizacion de celulas hematopoyeticas.
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
ATE274577T1 (de) * 1993-10-06 2004-09-15 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
AU715329B2 (en) * 1995-07-21 2000-01-20 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
SI1016414T1 (en) * 1998-12-17 2005-02-28 Applied Research Systems Ars Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
US20040028649A1 (en) * 2000-06-07 2004-02-12 GIANNI Alessandro Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
JP2002534393A (ja) 2002-10-15
WO2000040260A1 (en) 2000-07-13
PT1140149E (pt) 2007-01-31
JP4808316B2 (ja) 2011-11-02
SI1140149T1 (sl) 2007-02-28
BR9916726A (pt) 2001-09-11
AU2004203355B2 (en) 2007-05-17
US20060029581A1 (en) 2006-02-09
IL143994A0 (en) 2002-04-21
AU772222B2 (en) 2004-04-22
EP1779865A1 (en) 2007-05-02
ES2275359T3 (es) 2007-06-01
DE69933581D1 (de) 2006-11-23
AU2103900A (en) 2000-07-24
AU2004203355A1 (en) 2004-08-19
EP1140149B1 (en) 2006-10-11
ATE342064T1 (de) 2006-11-15
EP1016413A1 (en) 2000-07-05
IL143994A (en) 2009-06-15
EP1140149A1 (en) 2001-10-10
CA2354194A1 (en) 2000-07-13
CY1107603T1 (el) 2013-03-13
DE69933581T2 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
Roux et al. Immunosuppressive mesenchymal stromal cells derived from human-induced pluripotent stem cells induce human regulatory T cells in vitro and in vivo
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
ATE253112T1 (de) Menschliche hematopoietische stammzellen
DK1526172T3 (da) Fremgangsmåde til replikation af influenzavira i cellekultur og ved fremgangsmåden opnåelige influenzavira
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
WO2006047743A3 (en) Swine multipotent adult progenitor cells
WO2000001231A3 (en) Improved methods for storing neural cells
FI890821A (fi) Menetelmä kudossiirtoon soveltuvien, in vitro-viljeltyjen epiteelikalvojen säilyttämiseksi
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
Najar et al. Foreskin as a source of immunotherapeutic mesenchymal stromal cells
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
MXPA02003732A (es) Preparacion y seleccion de celulas donadoras para transplante nuclear.
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
WO1993009234A3 (en) Suppressor and progenitor cells
ATE361975T1 (de) Tiermodell für hepatitis-virus infektion
SG146623A1 (en) Rodent expression systems utilising polyoma virus and epstein barr virus sequences
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
WO2005032463A3 (en) Educated nkt cells and their uses in the treatment of immune-related disorders
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
PT765398E (pt) Populacao de celulas enriquecedoras em progenitores mieloides e linfoides e metodos de as fazer e utilizar